David D Roberts - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David D Roberts

Showing results (141-150 of 165) with videos related to

Pageof 17

Sort By:

Matrix Biology : Journal of the International Society for Matrix Biology|November 29, 2007

TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assemblySvetlana A Kuznetsova, David J Mahoney, Gema Martin-Manso, et al.

Cardiovascular Research|July 9, 2010

Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxationEileen M Bauer, Yan Qin, Thomas W Miller, et al.

Blood|November 4, 2006

Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxationJeff S Isenberg, Fuminori Hyodo, Ken-Ichiro Matsumoto, et al.

Plos One|April 3, 2020

A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncologyTeresa L Burgess, Joshua D Amason, Jeffrey S Rubin, et al.

Oncotarget|February 4, 2016

A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancerSukhbir Kaur, Abdel G Elkahloun, Satya P Singh, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2014

CD47 signaling regulates the immunosuppressive activity of VEGF in T cellsSukhbir Kaur, Tiffany Chang, Satya P Singh, et al.

Autophagy|August 10, 2012

CD47 deficiency confers cell and tissue radioprotection by activation of autophagyDavid R Soto-Pantoja, Thomas W Miller, Michael L Pendrak, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009

Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cellsSara E Bass, Pawel Sienkiewicz, Christopher J Macdonald, et al.

Nature Communications|January 12, 2012

Programmable multivalent display of receptor ligands using peptide nucleic acid nanoscaffoldsEthan A Englund, Deyun Wang, Hidetsugu Fujigaki, et al.

Journal of Cell Science|October 19, 2006

Versican-thrombospondin-1 binding in vitro and colocalization in microfibrils induced by inflammation on vascular smooth muscle cellsSvetlana A Kuznetsova, Philip Issa, Elizabeth M Perruccio, et al.

Pageof 17

Search research articles

Showing results (141-150 of 165) with videos related to

Sort By:

Pageof 17

Matrix Biology : Journal of the International Society for Matrix Biology|November 29, 2007

TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assemblySvetlana A Kuznetsova, David J Mahoney, Gema Martin-Manso, et al.

Cardiovascular Research|July 9, 2010

Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxationEileen M Bauer, Yan Qin, Thomas W Miller, et al.

Blood|November 4, 2006

Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxationJeff S Isenberg, Fuminori Hyodo, Ken-Ichiro Matsumoto, et al.

Plos One|April 3, 2020

A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncologyTeresa L Burgess, Joshua D Amason, Jeffrey S Rubin, et al.

Oncotarget|February 4, 2016

A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancerSukhbir Kaur, Abdel G Elkahloun, Satya P Singh, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2014

CD47 signaling regulates the immunosuppressive activity of VEGF in T cellsSukhbir Kaur, Tiffany Chang, Satya P Singh, et al.

Autophagy|August 10, 2012

CD47 deficiency confers cell and tissue radioprotection by activation of autophagyDavid R Soto-Pantoja, Thomas W Miller, Michael L Pendrak, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009

Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cellsSara E Bass, Pawel Sienkiewicz, Christopher J Macdonald, et al.

Nature Communications|January 12, 2012

Programmable multivalent display of receptor ligands using peptide nucleic acid nanoscaffoldsEthan A Englund, Deyun Wang, Hidetsugu Fujigaki, et al.

Journal of Cell Science|October 19, 2006

Versican-thrombospondin-1 binding in vitro and colocalization in microfibrils induced by inflammation on vascular smooth muscle cellsSvetlana A Kuznetsova, Philip Issa, Elizabeth M Perruccio, et al.

Pageof 17